How to follow the guidelines, when the appropriate fluid is missing?
David W. Brossier,Isabelle Goyer,Claire Morice,Fahad Alsohime,Huw F. Mayberry,Florence Porcheret,Lyvonne N. Tume,Frederic V. Valla,Sophie Beldjilali,Fabrizio Chiusolo,Leonardo Costa,Capucine Didier,Stavroula Ilia,Nyandat L Joram,Corinne Jotterand Chaparro,Martin CJ Kneyber,Eva Kühlwein,Jorge Lopez,Jesus López-Herce,Luise V. Marino,Fortesa Mehmeti,Magdalena Mierzewska-Schmidt,MarIa Miñambres Rodríguez,Clémence Moullet,John V. Pappachan,Leonor Reis Boto,Shancy Rooze,Luregn J Schlapbach,Hakan Tekguc,Konstantinos Tziouvas,Sascha CAT Verbruggen,on behalf of the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) IVMFT group
DOI: https://doi.org/10.1007/s00431-024-05514-6
2024-03-19
European Journal of Pediatrics
Abstract:Intravenous maintenance fluid therapy (IV-MFT) is probably the most prescribed drug in paediatric hospital care. Recently paediatric societies have produced evidence-based practice guidelines that recommend the use of balanced isotonic fluid when prescribing IV-MFT in both acute and critical paediatric care. Unfortunately, the applicability of these guidelines could be called into question when a ready-to-use glucose-containing balanced isotonic fluid is not available. The main objective of this study was to describe the availability of glucose-containing balanced isotonic fluids in European and Middle Eastern paediatric acute and critical care settings. This work is an ancillary study of the survey dedicated to IV-MFT practices in the paediatric acute and critical care settings in Europe and Middle East, a cross-sectional electronic 27-item survey, emailed in April–May 2021 to paediatric critical care physicians across 34 European and Middle East countries. The survey was developed by an expert multi-professional panel within the European Society of Peadiatric and Neonatal Intensive Care (ESPNIC). Balanced isotonic fluid with glucose 5% was available for only 32/153 (21%) responders. Balanced isotonic fluid with glucose 5% was consistently available in the UK (90%) but not available in France, Greece, The Netherlands and Turkey.
pediatrics